Introduction
============

Heart failure (HF), a cardiac disease, is an important concern owing to its high prevalence and associated mortality. There are more than 6.5 million adults with HF in the United States ([@B1]). In Japan, the number of patients with HF is expected to reach 1.2 million by 2020 ([@B2]).

HF is often caused by ischemic heart disease, hypertension, or valvular disease ([@B3]-[@B5]). However, many cases of HF are also caused by systemic diseases and malignant tumors. Hence, patients with HF are likely to be examined by both cardiologists and non-cardiologists at hospitals or clinics. For example, there are various symptoms and causes of Takotsubo cardiomyopathy, and case reports have been published from different types of hospital and clinical departments. Thus, non-cardiologists must understand HF, and cardiologists must be aware of the underlying non-cardiovascular diseases that can lead to HF.

Learning the differential diagnoses of HF will help both cardiologists and non-cardiologists. The studies conducted by Harrison ([@B6]), Goldman-Cecil ([@B7]), and Braunwald ([@B8]) provide a systematic understanding of HF. However, these studies cannot be expected to have completely described the diversity of HF cases; furthermore, frequent updates are difficult to carry out.

The Taiwan National Health Insurance Program is a nationwide initiative; its database contains detailed background characteristics of patients with HF ([@B9]). However, in the database, it is unclear what percentage of cases was compiled by non-cardiologists. Consequently, we sought to clarify the nature of the underlying diseases and HF-related fatalities by analyzing case reports presented at the Japanese Society of Internal Medicine. Of note, these reports originated from both cardiovascular and non-cardiovascular departments.

Materials and Methods
=====================

The Japanese Society of Internal Medicine holds regional meetings in Japan (e.g. in the Kanto region, Kinki region, etc.) nine times a year. Since 1946, 1,000 case reports have been presented at these meetings. Since 2002, reports presented at regional meetings across Japan have been published on the conference website, and the total number of reports in the conference database now exceeds 49,000.

Using an editing tool for abstracts (Shourei-Kun; <https://www.naika.or.jp/info/info_kensaku/>), we examined 49,693 case reports from the Japanese Society of Internal Medicine database deposited from 2002 to 2017. We excluded 46,022 reports that did not include the phrase "heart failure" based on a simple text search. After peer-reviewing the abstracts, we also excluded 778 reports with no reported symptoms of HF. We also determined the basal disease, reporting department, and prognosis for the remaining 2,893 cases with HF (5.8% of 49,693 case reports; [Fig. 1](#g001){ref-type="fig"}). The prognosis was classified as dead or alive, according to the abstracts.

![Flowchart of the search for case reports on heart failure.](1349-7235-58-2145-g001){#g001}

The cases originated across the following 10 department types: 1) cardiology, 2) allergy and rheumatology, 3) general internal medicine, 4) infectious disease, 5) hematology, 6) respiratory medicine, 7) gastroenterology, 8) neurology, 9) nephrology, and 10) endocrinology and metabolism. We further classified the cases into the following 18 categories: 1) cardiovascular disease, 2) congenital heart disease, 3) cardiac tumor, 4) connective tissue diseases, 5) infectious diseases, 6) hematological diseases, 7) respiratory diseases, 8) gastrointestinal hepatic, biliary and pancreatic diseases, 9) neurological diseases, 10) kidney diseases, 11) endocrine diseases, 12) malignant tumors, 13) hematological malignancies, 14) inflammatory disorders, 15) systemic disorders, 16) genetic disorders, 17) side effects, and 18) others. [Supplementary material 1](#s001){ref-type="supplementary-material"} presents the cases classified under connective tissue diseases, systemic disorders, and genetic disorders. We subsequently combined categories 1)-3) as cardiovascular disease cases and categories 4)-18) as non-cardiovascular disease cases.

We used an unpaired *t*-test and analysis of variance (ANOVA) to evaluate and compare, respectively, the percentage of fatal HF cases among the case reports originating from the cardiovascular and non-cardiovascular departments. We analyzed all data using the Statistical Package for the Social Sciences software program (SPSS v.16.0; Chicago, USA). p\<0.05 was considered statistically significant.

Results
=======

Of the 2,893 total case reports on HF, 1,952 (67.5%) and 941 (32.5%) originated from cardiovascular and non-cardiovascular departments, respectively ([Table 1](#t001){ref-type="table"}). The etiology was cardiovascular disease in 1,181 cases (40.8%) and non-cardiovascular disease in 1,712 (59.2%).

###### 

Case Reports of Heart Failure Classified by Department of Origin.

  Department                     Number of reports   Case reports with the phrase "heart failure" in the title or abstract   Cases of heart failure
  ------------------------------ ------------------- ----------------------------------------------------------------------- ------------------------
  Cardiology                     7,761               2,285                                                                   1,952 (67.5)
  Allergy and rheumatology       3,983               132                                                                     111 (3.8)
  General internal medicine      423                 16                                                                      13 (0.4)
  Infectious diseases            3,952               114                                                                     64 (2.2)
  Hematology                     4,728               170                                                                     126 (4.4)
  Respiratory medicine           5,685               201                                                                     144 (5.0)
  Gastroenterology               8,419               160                                                                     69 (2.4)
  Neurology                      4,634               89                                                                      50 (1.7)
  Nephrology                     3,535               203                                                                     132 (4.6)
  Endocrinology and metabolism   6,573               301                                                                     232 (8.0)
  Total                          49,693              3,671                                                                   2,893 (100)

Data is shown as number or percentage of originating department in cases of heart failure.

###### 

Underlying Diseases Implicated in More than 10 Cases.

  Disease                               Number                                                         
  ---------------------------------- -- -------- -- ----------------------------------------------- -- ----
  Amyloidosis                           155         Hypertrophic obstructive cardiomyopathy            19
  Ischemic heart disease                112         Acromegaly                                         19
  Infectious endocarditis               89          Hyperthyroidism                                    17
  Dilated cardiomyopathy                71          Multiple myeloma                                   16
  Takotsubo myopathy                    69          Vasospastic angina                                 16
  Sarcoidosis                           66          Acute myocarditis                                  16
  Acute myocardial infarction           65          Fulminant myocarditis                              16
  Vitamin B1 deficiency                 44          Hypertensive heart disease                         16
  Thyroid crisis                        43          Polymyositis                                       15
  Systemic lupus erythematosus          35          Pulmonary tumor thrombotic microangiopathy         15
  Graves' disease                       35          Malignant hypertension                             14
  Aortic valve stenosis                 34          Anthracycline-associated                           13
  Eosinophilic myocarditis              34          Pulmonary hypertension                             12
  Atrial fibrillation                   32          Trastuzumab-associated                             12
  Constrictive pericarditis             31          Corrected transposition of the great arteries      12
  Non-compaction                        31          Sjögren's syndrome                                 11
  Peripartum cardiomyopathy             30          Rheumatoid arthritis                               11
  Hyperthyroidism                       30          Tuberculous pericarditis                           11
  Malignant lymphoma                    29          Cushing's syndrome                                 11
  Mitochondrial disease                 28          Lung cancer                                        11
  Systemic scleroderma                  26          Crow-Fukase's syndrome                             11
  Aortitis syndrome                     24          Acute coronary syndrome                            10
  Obesity hypoventilation syndrome      23          After mitral valve replacement                     10
  Mitral regurgitation                  22          Dermatomyositis                                    10
  Pheochromocytoma                      20          Sleep apnea syndrome                               10
  Renal artery stenosis                 19          Fabry disease                                      10

[Table 2](#t002){ref-type="table"} presents the underlying diseases for more than 10 cases. Amyloidosis and sarcoidosis were the major underlying non-cardiovascular diseases, whereas ischemic heart disease, dilated cardiomyopathy, Takotsubo cardiomyopathy, and infective endocarditis were the major underlying cardiovascular diseases. [Fig. 2](#g002){ref-type="fig"} presents the underlying diseases (total 30) and the originating department of each case of Takotsubo cardiomyopathy; although the reports were mostly from cardiology departments (68.1%), the major underlying causes were endocrine disease (20.2%), infectious disease (13.0%), respiratory disease (7.2%), and nervous disease (7.2%).

![Causes of diseases (A) and the originating departments (B) for the case reports on Takotsubo cardiomyopathy.](1349-7235-58-2145-g002){#g002}

In all, 725 diseases were identified, including 196 (27.0%) types of cardiovascular disease and 529 (73.0%) types of non-cardiovascular diseases. In addition, 91 different side effects were identified ([Fig. 3](#g003){ref-type="fig"}). [Fig. 4](#g004){ref-type="fig"} shows the percentage of fatal HF cases according to the originating department. The percentages of fatal HF cases were high among the reports originating from the hematology (27.0%), respiratory medicine (30.6%), and gastroenterology (27.7%) departments. The percentage of fatal HF cases was significantly higher among reports originating from non-cardiovascular departments than among those originating from cardiovascular departments (17.8% vs. 10.8%, respectively; p\<0.001). The diseases implicated in more than 10 cases were pulmonary tumor thrombotic microangiopathy (PTTM; 87%), multiple myeloma (50%), and amyloidosis (47%). These diseases accounted for the highest percentages of HF-related mortality. The number of reported PTTM cases (by year) is presented in [Table 3](#t003){ref-type="table"}. Although PTTM is associated with a high mortality rate, surviving cases were reported in 2012 and 2017.

![The number of diseases identified in 18 categories.](1349-7235-58-2145-g003){#g003}
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###### 

Reported Number of Pulmonary Tumor Thrombotic Microangiopathies by Year.

  Year      Alive report      Death report
  ------ -- -------------- -- --------------
  2006      0                 1
  2007      0                 0
  2008      0                 0
  2009      0                 0
  2010      0                 1
  2011      0                 2
  2012      1                 2
  2013      0                 1
  2014      0                 1
  2015      0                 3
  2016      0                 1
  2017      1                 1

Discussion
==========

HF case reports accounted for 5.8% of all internal medicine case reports. Of the 2,893 cases of HF, 40% were caused by cardiovascular diseases; however, the underlying cardiovascular disease was identified in only 20% of all cases.

We assessed all cases of HF in our conference database to determine the different underlying diseases. It has recently become possible to perform the differential diagnosis of HF using information available on the Internet (e.g. websites like UpToDate.com.) and in medical textbooks (e.g. those authored by Harrison, Goldman-Cecil, Braunwald, etc.) ([@B6]-[@B8]). The leading textbooks are growing thicker each year with the increase in knowledge concerning these diseases, making the Internet increasingly useful for its convenience and ease of access. However, the information available on the Internet is not always up-to-date due to delays in publication; furthermore, racial differences in the available sources may exist. In Japan, Takotsubo cardiomyopathy is a cause of HF, and in recent years, this disease has been frequently reported and garnered substantial attention ([@B10]). However, because there are several causes of Takotsubo cardiomyopathy, the relevant reports have originated from different types of hospitals and clinical departments. In the present study, we identified 725 separate disease designations. It is thus impractical to describe all of the potential underlying diseases in a single textbook. However, using case reports from the Regional Meeting of the Japanese Society of Internal Medicine database, we were able to investigate the details of the underlying diseases in recent cases of HF, including Takotsubo cardiomyopathy. The side effects of various therapeutic drugs could also be quickly checked using this database.

We found that a high percentage of HF-related mortality was attributable to PTTM, multiple myeloma, and amyloidosis. The differential diagnosis is therefore extremely important for clinicians. Both amyloidosis and sarcoidosis are systemic diseases. When non-cardiologists diagnose a systemic disease, they should pay attention to HF. Cardiologists should be able to properly diagnose and treat HF associated with systemic diseases. In the present study, PTTM was the underlying cause of HF-related mortality in many early autopsy reports; however, surviving cases have recently been reported. The first report of a patient with PTTM was published in 1990 ([@B11]), and the first such report in Japan was published in 1995 ([@B12]). The recently increasing PTTM incidence may be due to an improved disease understanding. Further reports of detailed autopsy investigations in HF may help improve the quality of the diagnosis, treatment, and prognosis for rare diseases that cause HF.

In the present study, we attempted to elucidate the different etiologies of HF based on a large database of case reports. Of note, case reports (by their nature) often depict special or rare cases, so the disease frequencies and severities determined purely from case reports may differ from the actual status. However, the enumeration of many differential diagnoses is advantageous for the accurate diagnosis of HF etiologies and for identifying the underlying diseases most commonly associated with high mortality. In the future, by continued the annual updating of case reports, the number of diseases associated with HF will continue to increase, and the expanding database will improve our ability to differentially diagnose patients and determine the prognosis of HF.

Conclusion
==========

Many cases of HF are caused by non-cardiovascular diseases. To improve our ability to clinically diagnose HF, it is necessary to examine the underlying non-cardiovascular diseases of HF. A broad study of case reports on internal medicine is important for cardiologists.
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